Skip survey header

Ending the Syndemic: Fentanyl and OUD - July 26, 2024

Cardea Services 
 
Questions about this evaluation? Email info@cardeaservices.org. 
 
We hope you found this educational offering both interesting and informative. Your anonymous responses will be used to plan future educational activities. 
2. Have you ever participated in an ECHO before?
3. Does your clinic/organization have a policy and/or protocol to address the following: 
Space Cell YesNo
HIV Prevention
HIV Screening
HIV Treatment
Identifying who may benefit from PrEP
Prescribing PrEP
Syphilis Prevention
Syphilis Screening
Syphilis Treatment
Syphilis Standing Orders
Syphilis Field Based Treatment
Hepatitis C Prevention
Hepatitis C Screening
Hepatitis C Treatment
Substance Use Disorder Prevention
Substance Use Disorder Screening
Substance Use Disorder Treatment
Harm Reduction Services
4. Does your clinic/organization have specific programming (i.e. funding, clinics, physicians, etc.)
Space Cell YesNo
HIV
PrEP
Syphilis
Hepatitis C
Substance Use Disorders
Harm Reduction
5. In any given month, approximately how many patients do you estimate you are treating for... 
7. How satisfied are you with this learning activity?
Very satisfiedSatisfiedUnsatisfiedVery unsatisfied
8.  As a result of this learning activity, how has your knowledge on this topic changed?  *This question is required.
Improved a lotImproved a littleStayed the sameGot worse
9. As a result of this learning activity, *This question is required.
Space Cell Very likelyLikelyUnlikelyVery unlikely
I am able to manage the care of my patients who have taken fentanyl and my patients with opioid use disorder.
I am able to discuss the components of harm reduction education.
10.  I plan to make one change in practice based on what I learned in this activity. *This question is required.
Very likelyLikelyUnlikelyVery unlikely
Why are you unlikely to make a change? *This question is required.